A Review on Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of Pancreatic Lesions-Reference-Cited by-同舟云学术

A Review on Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of Pancreatic Lesions

Published:2023-02-01 Issue:3 Volume:13 Page:536
ISSN:2075-4418
Container-title:Diagnostics
language:en
Short-container-title:Diagnostics

Author:

Karaisz Fred G.¹,Elkelany Osama O.²,Davies Benjamin³,Lozanski Gerard⁴,Krishna Somashekar G.¹^ORCID

Affiliation:

1. Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA

2. Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA

3. College of Medicine, The Ohio State University, Columbus, OH 43210, USA

4. Department of Pathology, The Ohio State University Wexner Medical Center, Columbus OH 43210, USA

Abstract

The morbidity associated with pancreatectomies limits surgical options for high-risk patients with pancreatic neoplasms that warrant resection. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) offers a minimally invasive and potentially definitive means to treat pancreatic neuroendocrine tumors and precancerous pancreatic cystic lesions. In addition, EUS-RFA may play a role in the treatment and palliation of non-surgical cases of pancreatic adenocarcinoma. The efficacy of RFA appears to be further enhanced by systemic immunomodulatory effects. Here, we review current studies on the developing role of EUS-RFA in these pancreatic pathologies.

Publisher

MDPI AG

Subject

Clinical Biochemistry

Link

https://www.mdpi.com/2075-4418/13/3/536/pdf

Reference103 articles.

1. Pancreatic cancer: A review of epidemiology, trend, and risk factors;Hu;World J. Gastroenterol.,2021

2. The Durability of EUS-Guided Chemoablation of Mucinous Pancreatic Cysts: A Long-Term Follow-Up of the CHARM trial;Lester;Clin. Gastroenterol. Hepatol.,2021

3. Irreversible electroporation: A novel pancreatic cancer therapy;Weiss;Curr. Probl. Cancer,2013

4. Irreversible electroporation for the treatment of pancreatic neuroendocrine tumors;Papamichail;Korean J. Hepato-Biliary-Pancreat. Surg.,2016

5. Palliative therapy in pancreatic cancer—Interventional treatment with radiofrequency ablation/irreversible electroporation;Paiella;Transl. Gastroenterol. Hepatol.,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EUS–radiofrequency ablation for pancreatic neuroendocrine tumors: is there a promising future?;Endoscopic Ultrasound;2024-09-11

2. Harnessing endoscopic ultrasound-guided radiofrequency ablation to reshape the pancreatic ductal adenocarcinoma microenvironment and elicit systemic immunomodulation;Exploration of Targeted Anti-tumor Therapy;2024-08-15

3. EUS-guided radiofrequency ablation in pancreatic cancer: Promising but still questionable!;Gastrointestinal Endoscopy;2024-08

4. Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application;Frontiers in Immunology;2024-05-02

5. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic tumors;Current Opinion in Gastroenterology;2024-04-12